219 related articles for article (PubMed ID: 19396443)
21. Molecular cloning, expression and enzymatic assay of pteridine reductase 1 from Iranian lizard Leishmania.
Kazemi B; Tohidi F; Bandehpour M; Yarian F
Iran Biomed J; 2010 Jul; 14(3):97-102. PubMed ID: 21079660
[TBL] [Abstract][Full Text] [Related]
22. Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery.
das Neves GM; Kagami LP; Gonçalves IL; Eifler-Lima VL
Future Med Chem; 2019 Aug; 11(16):2107-2130. PubMed ID: 31370699
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines.
de Souza Moreira D; Ferreira RF; Murta SM
Exp Parasitol; 2016 Jan; 160():60-6. PubMed ID: 26689884
[TBL] [Abstract][Full Text] [Related]
24. Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites.
Gourley DG; Schüttelkopf AW; Leonard GA; Luba J; Hardy LW; Beverley SM; Hunter WN
Nat Struct Biol; 2001 Jun; 8(6):521-5. PubMed ID: 11373620
[TBL] [Abstract][Full Text] [Related]
25. Mutant PTR1 proteins from Leishmania tarentolae: comparative kinetic properties and active-site labeling.
Chang CF; Bray T; Whiteley JM
Arch Biochem Biophys; 1999 Aug; 368(1):161-71. PubMed ID: 10415124
[TBL] [Abstract][Full Text] [Related]
26. Delving in folate metabolism in the parasite Leishmania major through a chemogenomic screen and methotrexate selection.
Bigot S; Leprohon P; Ouellette M
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011458. PubMed ID: 37384801
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the ternary complex of Leishmania major pteridine reductase 1 with the cofactor NADP
Dello Iacono L; Di Pisa F; Mangani S
Acta Crystallogr F Struct Biol Commun; 2022 Apr; 78(Pt 4):170-176. PubMed ID: 35400669
[TBL] [Abstract][Full Text] [Related]
28. In Silico and In Vitro Search for Dual Inhibitors of the
Possart K; Herrmann FC; Jose J; Schmidt TJ
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005256
[TBL] [Abstract][Full Text] [Related]
29. Biochemical and Genetic Tests for Inhibitors of Leishmania Pteridine Pathways.
Hardy LW; Matthews W; Nare B; Beverley SM
Exp Parasitol; 1997 Nov; 87(3):158-70. PubMed ID: 9398595
[TBL] [Abstract][Full Text] [Related]
30. Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
Pöhner I; Quotadamo A; Panecka-Hofman J; Luciani R; Santucci M; Linciano P; Landi G; Di Pisa F; Dello Iacono L; Pozzi C; Mangani S; Gul S; Witt G; Ellinger B; Kuzikov M; Santarem N; Cordeiro-da-Silva A; Costi MP; Venturelli A; Wade RC
J Med Chem; 2022 Jul; 65(13):9011-9033. PubMed ID: 35675511
[TBL] [Abstract][Full Text] [Related]
31. Structures of Leishmania major pteridine reductase complexes reveal the active site features important for ligand binding and to guide inhibitor design.
Schüttelkopf AW; Hardy LW; Beverley SM; Hunter WN
J Mol Biol; 2005 Sep; 352(1):105-16. PubMed ID: 16055151
[TBL] [Abstract][Full Text] [Related]
32. Degradation of pteridine reductase 1 (PTR1) enzyme during growth phase in the protozoan parasite Leishmania donovani.
Kumar P; Sundar S; Singh N
Exp Parasitol; 2007 Jun; 116(2):182-9. PubMed ID: 17275814
[TBL] [Abstract][Full Text] [Related]
33. Adaptation of Leishmania cells to in vitro culture results in a more efficient reduction and transport of biopterin.
Roy G; Kündig C; Olivier M; Papadopoulou B; Ouellette M
Exp Parasitol; 2001 Mar; 97(3):161-8. PubMed ID: 11312578
[TBL] [Abstract][Full Text] [Related]
34. Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms.
Drummelsmith J; Brochu V; Girard I; Messier N; Ouellette M
Mol Cell Proteomics; 2003 Mar; 2(3):146-55. PubMed ID: 12644573
[TBL] [Abstract][Full Text] [Related]
35. Selection against the dihydrofolate reductase-thymidylate synthase (DHFR-TS) locus as a probe of genetic alterations in Leishmania major.
Gueiros-Filho FJ; Beverley SM
Mol Cell Biol; 1996 Oct; 16(10):5655-63. PubMed ID: 8816478
[TBL] [Abstract][Full Text] [Related]
36. Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy.
Ubeda JM; Légaré D; Raymond F; Ouameur AA; Boisvert S; Rigault P; Corbeil J; Tremblay MJ; Olivier M; Papadopoulou B; Ouellette M
Genome Biol; 2008; 9(7):R115. PubMed ID: 18638379
[TBL] [Abstract][Full Text] [Related]
37. Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors.
Corona P; Gibellini F; Cavalli A; Saxena P; Carta A; Loriga M; Luciani R; Paglietti G; Guerrieri D; Nerini E; Gupta S; Hannaert V; Michels PA; Ferrari S; Costi PM
J Med Chem; 2012 Oct; 55(19):8318-29. PubMed ID: 22946585
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
[TBL] [Abstract][Full Text] [Related]
39. Disturbed biopterin and folate metabolism in the Qdpr-deficient mouse.
Xu F; Sudo Y; Sanechika S; Yamashita J; Shimaguchi S; Honda S; Sumi-Ichinose C; Mori-Kojima M; Nakata R; Furuta T; Sakurai M; Sugimoto M; Soga T; Kondo K; Ichinose H
FEBS Lett; 2014 Nov; 588(21):3924-31. PubMed ID: 25240194
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice.
Sienkiewicz N; Ong HB; Fairlamb AH
Mol Microbiol; 2010 Aug; 77(3):658-71. PubMed ID: 20545846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
